These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9519439)

  • 21. Predicting the yield of (177)Lu radionuclide produced by the cyclic irradiation technique.
    Odame Duodu G; Akaho EH; Serfor-Armah Y; Nyarko BJ; Afi Achoribo E
    Appl Radiat Isot; 2011 Mar; 69(3):588-93. PubMed ID: 21177113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "High specific activity" radiotracers for metallo-toxicological studies: cyclotron and nuclear reactor production, radiochemical separation and "quality control": platinum, iridium, gold, copper and gallium.
    Bonardi M; Groppi F; Birattari C; Arginelli D
    Ann Chim; 2002 Sep; 92(9):795-813. PubMed ID: 12407903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Numerical evaluation of the production of radionuclides in a nuclear reactor (Part II).
    Mirzadeh S; Walsh P
    Appl Radiat Isot; 1998 Apr; 49(4):383-95. PubMed ID: 9519445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
    Webster WD; Parks GT; Titov D; Beasley P
    Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STUDY OF AIRBORNE RADIOACTIVITIES IN THE OPERATION OF A HIGH FLUX RESEARCH REACTOR (CIR).
    SOMAN SD; ABRAHAM P
    Health Phys; 1965 Jun; 11():497-505. PubMed ID: 14325418
    [No Abstract]   [Full Text] [Related]  

  • 26. [The TRIGA - Mark II Nuclear Research Reactor: history and peculiarities].
    Salvini A
    G Ital Med Lav Ergon; 2020 Dec; 42(4):265-268. PubMed ID: 33600652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
    Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
    Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactors are indispensable for radioisotope production.
    Mushtaq A
    Ann Nucl Med; 2010 Dec; 24(10):759-60. PubMed ID: 20976574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate energy neutron beams from the MURR.
    Brugger RM; Herleth WH
    Basic Life Sci; 1990; 54():153-66. PubMed ID: 2268237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noble gas radionuclides in RBMK-1500-type reactor.
    Jasiulionis R; Adlys G; Adliene D; Vycinas L
    Appl Radiat Isot; 2007 Jul; 65(7):836-42. PubMed ID: 17383886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitation function for deuteron induced nuclear reactions on natural ytterbium for production of high specific activity 177g Lu in no-carrier-added form for metabolic radiotherapy.
    Manenti S; Groppi F; Gandini A; Gini L; Abbas K; Holzwarth U; Simonelli F; Bonardi M
    Appl Radiat Isot; 2011 Jan; 69(1):37-45. PubMed ID: 20801665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV.
    Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
    Phys Med Biol; 2015 Feb; 60(3):931-46. PubMed ID: 25574934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of recoil collection method for production of high specific activity nuclear medicine isotopes.
    Cheng KY; Kunze JF; Ehrhardt GJ
    Med Phys; 1999 Sep; 26(9):1843-6. PubMed ID: 10505873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alternate approach to the production of radioisotopes for nuclear medicine applications.
    D'Auria JM; Keller R; Ladouceur K; Lapi SE; Ruth TJ; Schmor P
    Rev Sci Instrum; 2013 Mar; 84(3):034705. PubMed ID: 23556835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a 2 MWth research reactor on radioactivity in sediments.
    Bose SR; Williamson TG; Mulder RU; Molla MA
    Health Phys; 1993 Aug; 65(2):200-8. PubMed ID: 8330968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.
    Bakht MK; Sadeghi M
    Ann Nucl Med; 2011 Oct; 25(8):529-35. PubMed ID: 21720780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioactivity levels in major French rivers: summary of monitoring chronicles acquired over the past thirty years and current status.
    Eyrolle F; Claval D; Gontier G; Antonelli C
    J Environ Monit; 2008 Jul; 10(7):800-11. PubMed ID: 18688446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactor-based management of used nuclear fuel: assessment of major options.
    Finck PJ; Wigeland RA; Hill RN
    Health Phys; 2011 Jan; 100(1):46-53. PubMed ID: 21399411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of Sn-117m in the BR2 high-flux reactor.
    Ponsard B; Srivastava SC; Mausner LF; Russ Knapp FF; Garland MA; Mirzadeh S
    Appl Radiat Isot; 2009; 67(7-8):1158-61. PubMed ID: 19303313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental and theoretical study of rhenium radioisotopes production for manufacturing of new compositional radiopharmaceuticals.
    Pourhabib Z; Ranjbar H; Bahrami Samani A; Shokri AA
    Appl Radiat Isot; 2019 Mar; 145():176-179. PubMed ID: 30639634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.